Titlebook: Management of Prostate Cancer; Eric A. Klein,J. Stephen Jones Book 2013Latest edition Springer Science+Business Media, LLC 2013 Brachyther

圖畫(huà)文字

fidelity

The Role of Obesity and Diet in Prostate Cancer,ied as obese (Fig. 8.1) (JAMA 303:235–241, 2010). Although the impact of obesity is hardest felt in the United States, international populations (i.e., central and eastern Europe) are currently observing trends for increasing obesity rates as well (BMC Public Health 8:200, 2008). Well known to be li

Abbreviate

Prostate Cancer Risk Reduction by Chemoprevention,ecrease the morbidity and mortality from the disease. Prostate cancer has been an attractive target for chemoprevention. Research has primarily focused on 5 alpha reductase inhibitors and nutrients including three large randomized placebo controlled trials published between 2003 and 2010 with a tota

ADJ

歹徒

Optimum Prostate Biopsy: Techniques and Strategies, in a considerable stage migration. Such results would not have been achieved without the contemporary refinements of the technique of prostate biopsy (PBx). PBx has evolved from the digitally guided transrectal biopsy, described by Astraldi in 1937, to the systematic biopsy method, described by Hod

尖酸一點(diǎn)

The Utility of Nomograms in Routine Clinical Practice,ural history. Physicians and patients must therefore rely upon estimates of relevant clinical outcomes when making medical decisions. Historically, physician judgment has formed the foundation of outcomes prediction. However, this method of prediction is inherently biased and unable to account for t

formula

Active Surveillance Comes of Age,ches to diagnosis. The widespread use of PSA for early detection has been associated with a significant fall in prostate cancer mortality in many regions. The cost, however, is a very high rate of diagnosis (and treatment) of prostate cancer. Many patients with indolent cancers who are not destined

BUDGE

Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Efirst feasible, focal therapy model. Recent data have demonstrated a significant pathologic stage migration towards earlier stage disease comprising unilateral pT2a/b prostate cancer (PCa). The cancer volume of the clinically significant tumor (represented by the index lesion) has been proposed as a

confide

說(shuō)笑